5 completed, 2 not yet recruiting, 2 recruiting, 2 unknown. 4 Not applicable, 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 2, Not yet recruiting 1, Unknown 1 |
| Phase 3 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow General Anxiety Disorder: new trials by email Literature Review of General Anxiety Disorder trials Research Report on General Anxiety Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Beneficial Effects of an Oral Nutritional Supplement Based on Leonurus Cardiaca for the Improvement of Mood and Anxiety Leonurus cardiaca extract 250 mg, Placebo, Leonurus cardiaca extract 500 mg - General Anxiety Disorder | Not applicable | Not yet recruiting | Azienda di Servizi alla Persona di Pavia | 60 | 2026-06-15 | 2025-11-25 |
| Clinical Trial to Evaluate the Efficacy and Safety of the Aurora® Digital Medical Device in Adult Patients With Moderate to Severe Generalized Anxiety Disorder App AURORA (Digital Therapy) + conventional treatment, Pharmacological conventional treatment - General Anxiety Disorder | Phase 3 | Recruiting | Psicofarma, S.A. De C.V. | 162 | 2026-03-29 | 2026-04-01 |
| Psychological State, Immunotherapy Response, and Multi-Omics Signatures in TNBC Breast Cancer Female NOS, General Anxiety Disorder | Recruiting | Fudan University | 120 | 2026-01-01 | 2025-12-18 | |
| Escitalopram Plasma Concentrations in Premenopausal and Postmenopausal Women Therapeutic Drug Monitoring (TDM), Menopause | Not yet recruiting | Eskisehir Osmangazi University | 94 | 2026-01-01 | 2025-12-22 | |
| Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Anxiety in Adolescents Modius Calm, Sham device - General Anxiety Disorder | Not applicable | Completed | Neurovalens Ltd. | 60 | 2025-09-08 | 2026-07-01 |
| A Dose-Response Safety Study of ENX-102 in Patients With GAD ENX-102, Placebo - General Anxiety Disorder | Phase 2 | Completed | Engrail Therapeutics INC | 38 | 2024-12-09 | 2025-09-17 |
| Interactive Voice Based Administration of the GAD 7 Paper GAD 7, Voice Administered GAD 7 - General Anxiety Disorder | Not applicable | Unknown | Oklahoma State University Center for Health Sciences | 40 | 2021-06-10 | 2022-04-21 |
| Emotional Brain Networks & Cognitive Functioning in Depression and Anxiety fMRI - Major Depressive Disorder, General Anxiety Disorder | Unknown | University of Electronic Science and Technology of China | 105 | 2016-07-01 | 2018-10-29 | |
| Training Protocol 'Drop it'. The Impact of a Training Protocol Focused on Coping With Negative Repetitive Thinking on Cognitive and Behavioural Functioning of People Suffering From GAD or Minor or Moderate Depressive Disorder or Depressive Disorder in Remission Drop It training session, treatment as usual - Repetitive Negative Thinking, General Anxiety Disorder | Not applicable | Completed | University Hospital, Ghent | 80 | 2013-10-01 | 2017-05-25 |
| At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions All Diagnosed Health Conditions, ADD/ADHD | Completed | Sanguine Biosciences | 17667 | 2013-07-01 | 2024-04-18 | |
| Evaluate the Safety of GABITRIL in Adults With Generalized Anxiety Disorder GABITRIL (tiagabine hydrochloride; CEP-6671) - General Anxiety Disorder | Phase 3 | Completed | Cephalon | 2003-08-01 | 2023-04-12 |
Generalized Anxiety Disorder (11) · Anxiety Disorders (3) · Breast Neoplasms (2) · Depression (2) · Depressive Disorder (2) · Depressive Disorder, Major (2) · Acquired Immunodeficiency Syndrome (1) · Alopecia Areata (1) · Anemia, Sickle Cell (1) · Arthritis, Psoriatic (1) · Asthma (1) · Bipolar Disorder (1) · Celiac Disease (1) · Cognitive Dysfunction (1) · Colitis, Ulcerative (1)
Mental Disorders (11) · Anxiety Disorders (8) · Mood Disorders (5) · Behavior (2) · Behavioral Symptoms (2) · Breast Diseases (2) · Cognition Disorders (2) · Depressive Disorder (2) · Digestive System Diseases (2) · Gastrointestinal Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Neurocognitive Disorders (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2)
Magnetic Resonance Imaging (1) · Therapeutics (1) · Tiagabine (1)
Azienda di Servizi alla Persona di Pavia (1) · Cephalon (1) · Engrail Therapeutics INC (1) · Eskisehir Osmangazi University (1) · Fudan University (1) · Neurovalens Ltd. (1) · Oklahoma State University Center for Health Sciences (1) · Psicofarma, S.A. De C.V. (1) · Sanguine Biosciences (1) · University Hospital, Ghent (1) · University of Electronic Science and Technology of China (1)
United States (3) · China (2) · Belgium (1) · India (1) · Mexico (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Benjamin Becker, Dr. (1) · Charles Brown, MD (1) · Houman Hemmati, MD (1) · Jason Beaman, D.O. (1) · Kimberly Vanover, PhD (1) · Sai Sailesh Kumar Goothy (1)